Functioning outcomes with adjunctive treatments for major depressive disorder: a systematic review of randomized placebo-controlled studies

QR Code

Functioning outcomes with adjunctive treatments for major depressive disorder: a systematic review of randomized placebo-controlled studies

Emmanuelle Weiller,1 Catherine Weiss,2 Christopher P Watling,3 Christopher Edge,3 Mary Hobart,2 Hans Eriksson,1 Maurizio Fava4–6 1H. Lundbeck A/S, Valby, Copenhagen, Denmark; 2Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ, USA; 3Cambridge Medical Commun...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Weiller E, Weiss C, Watling CP, Edge C, Hobart M, Eriksson H, Fava M
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2017
Sujets:	Depression antidepressant adjunct Sheehan Disability Scale functional work Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/abdfed5f9cc94204b7f923f86fe3c5ef
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: post hoc analyses of three placebo-controlled studies
par: Thase ME, et autres
Publié: (2018)

Categorical improvements in disease severity in patients with major depressive disorder treated with vilazodone: post hoc analysis of four randomized, placebo-controlled trials
par: Durgam S, et autres
Publié: (2016)

Does Subjective Cognitive Function Mediate the Effect of Affective Temperaments on Functional Disability in Japanese Adults?
par: Toyoshima K, et autres
Publié: (2020)

Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a meta-analysis of randomized controlled trials
par: Luan SX, et autres
Publié: (2018)

Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
par: Kishi T, et autres
Publié: (2017)

Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3)
par: Zajecka JM, et autres
Publié: (2019)

Extent and Factors Associated with Adherence to Antidepressant Treatment During Acute and Continuation Phase Depression Treatment Among Older Adults with Dementia and Major Depressive Disorder
par: Bhattacharjee S, et autres
Publié: (2020)

Investigation of Adjuncts Use in J. F. Kennedy’s Speech for the Members of Congress and Diplomatic Corps of Latin America on 13 March 1961
par: Mercya Christ Sita Dewi
Publié: (2020)

Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
par: Novick D, et autres
Publié: (2016)

Factors impacting the efficacy of venlafaxine extended release 75–225 mg/day in patients with major depressive disorder: exploratory post hoc subgroup analyses of a randomized, double-blind, placebo-controlled study in Japan
par: Watanabe Y, et autres
Publié: (2018)

Different molecular targets, one purpose – treatment of depression
par: Burat Magdalena, et autres
Publié: (2020)

Depression and the use of antidepressants in cardiovascular diseases from a cardiologist’s perspective
par: Blat Diana, et autres
Publié: (2021)

Psicofarmacoterapia antidepresiva
par: Retamal C,Pedro
Publié: (2001)

Minocycline as adjunct therapy for a male patient with deficit schizophrenia
par: Chen X, et autres
Publié: (2018)

Evaluation Of Subjective Cognitive Function Using The Cognitive Complaints In Bipolar Disorder Rating Assessment (COBRA) In Japanese Adults
par: Toyoshima K, et autres
Publié: (2019)

Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder
par: Harada E, et autres
Publié: (2016)

A meta-analysis of levetiracetam for randomized placebo-controlled trials in patients with refractory epilepsy
par: Chen D, et autres
Publié: (2019)

El diagnóstico diferencial entre la Depresión Bipolar y la Depresión Monopolar en la práctica clínica
par: LEYTON A,FANNY, et autres
Publié: (2010)

Daily activity level improvement with antidepressant medications predicts long-term clinical outcomes in outpatients with major depressive disorder
par: Jha MK, et autres
Publié: (2017)

Medication use patterns, health care resource utilization, and economic burden for patients with major depressive disorder in Beijing, People’s Republic of China
par: Zhang L, et autres
Publié: (2016)

The isolation of online adjunct faculty and its impact on their performance
par: Véra L B Dolan
Publié: (2011)

Comparative effectiveness of switching paroxetine formulation for treatment of major depressive disorder: an open-label multicenter study
par: Otsubo T, et autres
Publié: (2018)

Cognitive impairment in depression: recent advances and novel treatments
par: Perini G, et autres
Publié: (2019)

Analysis of the association of MIR124-1 and its target gene RGS4 polymorphisms with major depressive disorder and antidepressant response
par: Zeng D, et autres
Publié: (2018)

Diagnosis and Treatment of Depression in Patients with Schizophrenia
par: Sergey N. Mosolov
Publié: (2020)

Patient Expectations and Experiences of Antidepressant Therapy for Major Depressive Disorder: A Qualitative Study
par: Baune BT, et autres
Publié: (2021)

Treatment response in relation to subthreshold bipolarity in patients with major depressive disorder receiving antidepressant monotherapy: a post hoc data analysis (KOMDD study)
par: Park YM, et autres
Publié: (2016)

Is Agomelatine Associated with Less Sedative-Hypnotic Usage in Patients with Major Depressive Disorder? A Nationwide, Population-Based Study
par: Hsing SC, et autres
Publié: (2020)

MarylandOnline's inter-institutional project to train higher education adjunct faculty to teach online
par: Julie Shattuck, et autres
Publié: (2011)

Predicting treatment outcomes of major depressive disorder by early improvement in painful physical symptoms: a pooled analysis of double-blind, placebo-controlled trials of duloxetine
par: Tokuoka H, et autres
Publié: (2017)

Pharmacogenetics of Antidepressants: from Genetic Findings to Predictive Strategies
par: L. K. Khokhlov, et autres
Publié: (2019)

¿Es efectivo que los antidepresivos aumentan el riesgo de suicidio?
par: Silva,Hernán, et autres
Publié: (2007)

Farmacoterapia de los trastornos depresivos unipolares en la mujer
par: Rees,Reginald
Publié: (2002)

The Relationship Between Baseline Clinical Symptom Characteristics and Working Ability in Japanese Patients Treated for Major Depressive Disorder and Painful Physical Symptoms
par: Sugawara N, et autres
Publié: (2020)

Preventive Approaches for Post-Stroke Depression: Where Do We Stand? A Systematic Review
par: Woranush W, et autres
Publié: (2021)

Novel Insights Into the Neurobiology of the Antidepressant Response From Ketamine Research: A Mini Review
par: Michael Colla, et autres
Publié: (2021)

Optimized regimens of combined medications for the treatment of major depressive disorder: a double-blind, randomized-controlled trial
par: Zuilhof Z, et autres
Publié: (2018)

Prevalence of Asymptomatic Venous Thromboembolism in Depressive Inpatients
par: Takeshima M, et autres
Publié: (2020)

ShenQi FuZheng injection as an adjunctive treatment to chemotherapy in breast cancer patients: a meta-analysis
par: Hongbo Zhang, et autres
Publié: (2019)

Mind your state: Insights into antidepressant nonadherence
par: De Wet Wolmarans, et autres
Publié: (2016)